729600-41-3

Basic information

• Product Name: Benzoic Acid, 4-[(2-Ethoxy-2-Oxoethyl)Amino]-, Methyl Ester
• Synonyms: Benzoic Acid, 4-[(2-Ethoxy-2-Oxoethyl)Amino]-, Methyl Ester;Benzoic Acid, 4-[(2-Ethoxy-2-Oxoethyl)Amino]-, Methyl Ester(WXC03555)
• CAS NO: 729600-41-3
• Molecular Formula: C₁₂H₁₅NO₄
• Molecular Weight: 237.2518
• Mol File: 729600-41-3.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzoic Acid, 4-[(2-Ethoxy-2-Oxoethyl)Amino]-, Methyl Ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic Acid, 4-[(2-Ethoxy-2-Oxoethyl)Amino]-, Methyl Ester(729600-41-3)
• EPA Substance Registry System: Benzoic Acid, 4-[(2-Ethoxy-2-Oxoethyl)Amino]-, Methyl Ester(729600-41-3)

Safety Data

• Hazardous Substances Data: 729600-41-3(Hazardous Substances Data)

Upstream product

• 105-36-2 ethyl bromoacetate 
• 619-45-4 4-methoxycarbonyl aniline 
• 623-73-4 diazoacetic acid ethyl ester 

Downstream Products

• 729600-43-5 4-(ethoxycarbonylmethylsulfamylamino)benzoic acid methyl ester 

Relevant articles and documents

Molecular Oxygen-Mediated Radical Alkylation of C(sp3)-H Bonds with Boronic Acids

A direct and site-specific alkylation of (sp3)C-H bond with aliphatic boronic acid was achieved. By simply heating glycinates and amines together with alkylboronic acids under an oxygen atmosphere, a variety of unnatural α-amino acids and peptides could b

SULFHYDANTOINS AS PHOSPHATE ISOSTERES FOR USE AS PHOSPHATASE INHIBITORS IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISORDERS

The present invention relates to novel phosphate isosteres. The invention relates to compounds having a sulfhydantoin or a reverse sulfhydantoin moiety, uses thereof, and related methods. The present invention relates to compounds of formula (I) or (II) : or pharmaceutically acceptable salts thereof; wherein Q, T, m, and X are as described herein. These compounds are inhibitors of phosphatases, particularly inhibitors of SHP-2. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing these compounds and compositions in the treatment of various phosphatase mediated diseases such as cancer and autoimmune disorders.